Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.
Boehm
Daniela
D
Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.
Gewurz
Benjamin E
BE
Kieff
Elliott
E
Cahir-McFarland
Ellen
E